<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01199094</url>
  </required_header>
  <id_info>
    <org_study_id>LRP5-HBM</org_study_id>
    <nct_id>NCT01199094</nct_id>
  </id_info>
  <brief_title>Clinical Assessment of Patients With High Bone Mass Due to Mutation in Lrp5</brief_title>
  <official_title>Clinical Assessment of Patients With High Bone Mass Due to Mutation in Low Density Lipoprotein l Receptor 5</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Odense University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to describe patients with a high bone mass phenotype due to a
      mutation in the low density lipoprotein l receptor 5 gene (LRP5) and compare them with age
      and sex matched controls. Moreover, bone density and microarchitecture as well as markers of
      bone metabolism are evaluated
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cases and controls are closely matched on age and sex and evaluated cross-sectionally.

      Dual x-ray absorptiometry (DXA) and high resolution peripheral quantitative computed
      tomography (HR-pQCT) are used in order to evaluate bone density as well as microarchitecture.
      Bone turnover markers and body composition are also measured.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">April 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Bone microarchitecture as assessed by high resolution quantitative computed tomography (HR-pQCT)</measure>
    <time_frame>12 weeks</time_frame>
    <description>HR-pQCT is used to evaluate bone microarchitecture, i.e. bone trabeculae, cortical thickness and trabecular number. Aim is to test if the microarchitecture of these patients are different that observed in normal controls</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in bone turnover markers</measure>
    <time_frame>12 weeks</time_frame>
    <description>Markers of bone resorption and formation are investigated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bone mineral density</measure>
    <time_frame>12 weeks</time_frame>
    <description>DXA is used to evaluate bone mineral density at total hip, spine, whole body and forearm.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">38</enrollment>
  <condition>Osteopetrosis</condition>
  <arm_group>
    <arm_group_label>Patients with mutation in the Lrp5 gene</arm_group_label>
    <description>Patients known to have a mutation in Lrp5 known to be causing a high bone mass phenotype</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum, plasma, DNA as well as fat and skin biopsies
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Case-control study on almost 40 individuals
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Lrp5 mutation/ADOI

        Exclusion Criteria:

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kim Brixen, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Odense University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Odense University Hospital, Osteoporosis Clinic</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <results_reference>
    <citation>Frost M, Andersen TE, Yadav V, Brixen K, Karsenty G, Kassem M. Patients with high-bone-mass phenotype owing to Lrp5-T253I mutation have low plasma levels of serotonin. J Bone Miner Res. 2010 Mar;25(3):673-5. doi: 10.1002/jbmr.44. Erratum in: J Bone Miner Res. 2010 Aug;25(8):1896.</citation>
    <PMID>20200960</PMID>
  </results_reference>
  <verification_date>August 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2010</study_first_submitted>
  <study_first_submitted_qc>September 9, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 10, 2010</study_first_posted>
  <last_update_submitted>September 9, 2010</last_update_submitted>
  <last_update_submitted_qc>September 9, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 10, 2010</last_update_posted>
  <responsible_party>
    <name_title>Kim Brixen, Professor, consultant</name_title>
    <organization>Odense University Hospital</organization>
  </responsible_party>
  <keyword>low density lipoprotein receptor 5</keyword>
  <keyword>high bone mass</keyword>
  <keyword>autosomal dominant osteopetrosis type I</keyword>
  <keyword>bone turnover markers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteopetrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

